ZFP36L2
mRNA decay activator protein ZFP36L2
Also known as: BRF2, ERF2, RNF162C, TIS11D, TISD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47974
- Gene
- ZFP36L2
- Ensembl
- ENSG00000152518
- Chromosome
- 2
- Canonical length
- 494 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene is a member of the TIS11 family of early response genes. Family members are induced by various agonists such as the phorbol ester TPA and the polypeptide mitogen EGF. The encoded protein contains a distinguishing putative zinc finger domain with a repeating cys-his motif. This putative nuclear transcription factor most likely functions in regulating the response to growth factors. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
494 residues, UniProt reviewed canonical sequence.
>P47974|ZFP36L2
1 MSTTLLSAFY DVDFLCKTEK SLANLNLNNM LDKKAVGTPV AAAPSSGFAP GFLRRHSASN
61 LHALAHPAPS PGSCSPKFPG AANGSSCGSA AAGGPTSYGT LKEPSGGGGT ALLNKENKFR
121 DRSFSENGDR SQHLLHLQQQ QKGGGGSQIN STRYKTELCR PFEESGTCKY GEKCQFAHGF
181 HELRSLTRHP KYKTELCRTF HTIGFCPYGP RCHFIHNADE RRPAPSGGAS GDLRAFGTRD
241 ALHLGFPREP RPKLHHSLSF SGFPSGHHQP PGGLESPLLL DSPTSRTPPP PSCSSASSCS
301 SSASSCSSAS AASTPSGAPT CCASAAAAAA AALLYGTGGA EDLLAPGAPC AACSSASCAN
361 NAFAFGPELS SLITPLAIQT HNFAAVAAAA YYRSQQQQQQ QGLAPPAQPP APPSATLPAG
421 AAAPPSPPFS FQLPRRLSDS PVFDAPPSPP DSLSDRDSYL SGSLSSGSLS GSESPSLDPG
481 RRLPIFSRLS ISDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFP36L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 208 nTPM
Expression across tissuesHPA
Tissue
- skin: 208 nTPM
- bone marrow: 184 nTPM
- adipose tissue: 177 nTPM
- ovary: 176 nTPM
- thyroid gland: 171 nTPM
- blood vessel: 169 nTPM
Single-cell type
- innate lymphoid cells: 1,799 nCPM
- t-cells: 1,567 nCPM
- epididymal basal cells: 1,553 nCPM
- basal keratinocytes: 1,314 nCPM
- hematopoietic stem cells: 1,272 nCPM
- nk-cells: 1,002 nCPM
Immune cell
- eosinophil: 82 nTPM
- memory CD8 T-cell: 63 nTPM
- neutrophil: 62 nTPM
- NK-cell: 53 nTPM
- myeloid DC: 51 nTPM
- gdT-cell: 47 nTPM
Brain region
- medulla oblongata: 225 nTPM
- spinal cord: 118 nTPM
- pons: 102 nTPM
- thalamus: 101 nTPM
- midbrain: 99 nTPM
- hypothalamus: 90 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZFP36L2.
Disease | AllUniProt
Conditions ZFP36L2 is implicated in, by any mechanism.
- Oocyte/zygote/embryo maturation arrest 13 (OZEMA13) MIM:620154
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 131 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Oocyte maturation defect 13
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.97
- gnomAD missense Z
- -1.84
- DepMap mean gene effect
- -0.31
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 3'-UTR-mediated mRNA destabilization
- cellular response to epidermal growth factor stimulus
- cellular response to fibroblast growth factor stimulus
- cellular response to glucocorticoid stimulus
- cellular response to granulocyte macrophage colony-stimulating factor stimulus
- cellular response to transforming growth factor beta stimulus
- cellular response to tumor necrosis factor
- definitive hemopoiesis
- ERK1 and ERK2 cascade
- hemopoiesis
- mRNA catabolic process
- negative regulation of fat cell differentiation
- negative regulation of mitotic cell cycle phase transition
- negative regulation of stem cell differentiation
- nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- regulation of B cell differentiation
- regulation of mRNA stability
- response to wounding
- somatic stem cell division
- somatic stem cell population maintenance
- T cell differentiation in thymus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZFP36L2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFP36L2 as an antibody target. Whether an autoantibody or antibody against ZFP36L2 could matter depends on whether native ZFP36L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFP36L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFP36L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...